Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why COVID Vaccines for Younger Kids Won't Win Authorization as Soon as Expected
Why COVID Vaccines for Younger Kids Won't Win Authorization as Soon as Expected
Why COVID Vaccines for Younger Kids Won't Win Authorization as Soon as Expected
Submitted by
admin
on August 6, 2021 - 11:25am
Source:
Motley Fool
News Tags:
Pfizer
BioNTech
Moderna Therapeutics
FDA
COVID-19
vaccines
pediatric
Headline:
Why COVID Vaccines for Younger Kids Won't Win Authorization as Soon as Expected
snippet:
Pfizer, BioNTech, and Moderna hope to win EUAs for their COVID-19 vaccines in protecting younger kids.
The FDA requested that the vaccine makers expand the sizes of their clinical trials.
While the increased number of study participants will push back EUA, it should have a minimal impact on these vaccine stocks.
Do Not Allow Advertisers to Use My Personal information
